degarelix accord
accord healthcare s.l.u. - degarelix acetate - prostatiske neoplasmer - other hormone antagonists and related agents - degarelix accord is a gonadotrophin releasing hormone (gnrh) antagonist indicated:for treatment of adult male patients with advanced hormone-dependent prostate cancer. for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.
buprenorphine "bluefish" 8 mg resoribletter, sublinguale
bluefish pharmaceuticals ab - buprenorphinhydrochlorid - resoribletter, sublinguale - 8 mg
suprecur 0,15 mg/dosis næsespray, opløsning
sanofi a/s - buserelinacetat - næsespray, opløsning - 0,15 mg/dosis
tegretal retard 400 mg depottabletter
europharma.dk aps - carbamazepin - depottabletter - 400 mg
marlodon 5 mg tabletter
eql pharma ab - methadonhydrochlorid - tabletter - 5 mg
agros pyraclostrobin emulsionskoncentrat
agros - pyraclostrobin - emulsionskoncentrat - 250 g/l pyraclostrobin
thiamine "sterop" 50 mg/ml injektionsvæske, opløsning
laboratoires sterop nv - thiaminhydrochlorid - injektionsvæske, opløsning - 50 mg/ml
cyanokit
serb sa - hydroxocobalamin - forgiftning - alle andre terapeutiske produkter - behandling af kendt eller formodet cyanidforgiftning. cyanokit administreres sammen med passende dekontaminering og støttende foranstaltninger.
topogyne 400 mikrogram tabletter
exelgyn - misoprostol - tabletter - 400 mikrogram
mifegyne 200 mg tabletter
exelgyn - mifepriston - tabletter - 200 mg